Gastrointestinal bleeding associated with myocardial infarction.
Gastrointestinal (GI) bleeding associated with myocardial infarcation (MI) often presents as a distinct syndrome that differs from either disease alone. MI is frequently overlooked in the setting of severe GI bleeding because the symptoms and signs of MI are frequently overshadowed by the severe bleeding. GI bleeding, particularly when massive, may precipitate MI from hypovolemia, hemodynamic compromise, and myocardial hypoperfusion. Esophagogastroduodenoscopy is safe in relatively clinically stable patients after MI and is indicated to evaluate significant upper GI bleeding.
Cappell
M S
MS
Division of Gastroenterology, Maimonides Medical Center, Brooklyn, New York, USA.
D003422:Critical Care / Q000379:methods; D016099:Endoscopy, Gastrointestinal / Q000379:methods / Q000592:standards; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011379:Prognosis; D012151:Resuscitation / Q000379:methods*; D012307:Risk Factors; D012449:Safety; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents